Industry Trends

Clinical Research
Off-shoring: A Country Attractiveness Index for Clinical Trials

By Mark P. Mathieu
For many years, pharmaceutical companies have been off-shoring manufacturing operations to lower-cost countries. Healthy margins and strong risk aversion have afforded pharmaceutical companies the luxury of staying close to home, for all but manufacturing activities. As financial pressures increase, pharmaceutical executives are finding that going offshore is not only less risky than it once was, but also too attractive to ignore.  Read More




More than Data Integration: A Vision for “eClinical”



By Bill Byrom

March 15, 2010 | Expert Commentary
| Last month, I considered clinical trial technologies that are core to every clinical trial (see, “Implementing Core Clinical Trial Technologies”). Now we’ll consider the vision for future integration of these solutions.

The aim of integration of technologies is certainly the sharing of common datato ensure that all systems have the most up to date information, data don’t need to be  re-keyed,  and discrepancies are reconciled between applications. For example, a CTMS application receiving live feeds of study recruitment and patient progress data from EDC and RTSM will ensure that the CTMS can be confidently consulted by senior management to provide an accurate picture of progress across the portfolio.

However, integrating common data between systems does not resolve all the areas that an eClinical solution should aim to address.  Data integration, for example, does not prevent sites from having to log in and out of different systems to achieve their workflow.  For example, entering screening data in EDC, logging out, logging into the web interface of the RTSM solution (IWR), randomizing a subject, returning to EDC to update the subject status and continue entering data.  Multiply this by the number of technologies a site must use in a particular study, and the number of studies they are running—many using different vendor solutions—and this becomes inefficient and difficult for busy site personnel. 

By further defining eClinical to represent combining technologies in such a way as to provide process-driven solutions tailored to the way clinical trials are operated by each key user type, we can begin to construct an enhanced vision for how solutions should work together.  Think first about other industries: single devices now  contain a collection of applications: mobile phone, MP3 player, camera, email system, electronic organizer etc., all once deployed independently, but now through a single interface.  Isn’t this the vision of how we’d like to see our technologies working together in the clinical trials arena—to de-clutter and enhance the way our sites and sponsors work with multiple solutions to manage their studies?

This future vision, then, could be expressed by meeting a number of objectives additional to simply integrating common data between systems:

Objective 1. Convergence of Technologies.  Convergence is the blurring of boundaries between once independent applications to create a seamless and highly optimized user experience.  Consider Microsoft Office.  This suite of products has some elements of convergence built in.  Create a chart in Excel, using the graphing module – and the exact same functionality can be accessed within PowerPoint and Word.  Expanding this concept to the core clinical trial technologies, if a site is using an EDC application to perform their patient-level activities around data management—it would be optimal for them to be able to perform other patient-level activities through this same system without exiting and entering another application.  Making activities such as randomization and medication dispensing accessible through the EDC interface is an example of this.  This doesn’t mean building EDC systems to contain all that functionality, but enabling them to access and utilize that functionality through integration with an RTSM system.  Making this happen, however, isn’t as simple as enabling a web-service connection between EDC and RTSM. Oother considerations need to be addressed:
• How is this functionality accessed through the EDC interface in a way that’s straightforward and logical for the user?
• Are special forms required within EDC to manage the new processes?
• How are errors and unexpected feedback from the RTSM system reported through the EDC interface?
• What happens if the user performs the RTSM action via IVR or another interface independent of the EDC application?
• What tools within the EDC study designer application need to be created to ensure the integration is configured correctly and data points mapped correctly between systems?
For a study manager the CTMS application may ideally be their primary interface.  Creating and activating user accounts for EDC and RTSM based on CTMS data by triggering actions within the CTMS application, might be an efficient way for them to triage access to study technologies.

None of these examples of convergence can be achieved easily without modifying individual applications to make the integration work effectively, but the objective is to blur the boundaries between applications in important areas where this blurring can make the use of combined technologies simpler for the user.

Objective 2. Data Consolidation for Effective Decision Making.  Consider a study manager wishing to assess the performance of their study.  They may be required to access independent reports within different internal and external systems.  RTSM may give real-time study progress data and information on the status of the supply chain; EDC on data management, query resolution and Source Data Verification progress; CTMS on progress against planned study milestone dates and budgeting; and so on.  Piecing together the full picture of study performance is time consuming if it depends upon collation of data and metrics from multiple sources.  An eClinical objective is to devise a way to draw data from across many systems and present in a consolidated way through a single interface.  A further advantage of this is the ability to enable users who do not have access to some of the source systems to have access to their data through the common interface.  Providing data in the most beneficial way will also mean deriving key performance indicators and metrics of value to the different user types and perspectives involved in measuring study performance and progress, in addition to provision of detailed data for those more intimately involved in aspects of the study.

Objective 3. A Common Technology Suite.  Microsoft Office became the leading provider for word-processing and spreadsheet software by combining these independent applications as components of a suite.  The common look and feel, navigational structure and menus across the suite applications mean that users familiar with one product find the others relatively intuitive.  In the eClinical vision, we see sites and sponsors overcoming the issues of having to learn and operate many different applications within and across their studies by utilizing applications that follow a common approach to their use and navigation.  Like convergence, this leads to the apparent feel of being in a single product, particularly if the user is not required to re-authenticate when navigating between individual applications within the suite.

Objective 4. Integrated Service Delivery.  So far we’ve focused on the products themselves, but a successful eClinical suite solution must also provide integrated service delivery.  The specification, configuration and development of each component application must be delivered in a coordinated manner, to ensure all pieces and the underlying integration can be delivered on time and fully end-to-end tested.  This requires oversight by a single project manager.  Once live, users should be able to receive support from a single help desk independent of the technology solution they are experiencing difficulty with.  Combined with the technology vision of convergence, data convergence and the product suite concept, integrated support and service is the final component of this eClinical vision.


Bill Byrom is the senior director of Product Strategy, Perceptive Informatics, Nottingham, UK

 

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

Life Science Webcasts & Podcasts

medidata podcast #8 Meeting Today’s Challenges in Clinical Trial Supply Management
Sponsored by: Medidata Solutions Worldwide  

Setting up and managing the clinical trial involves many complex procedures. Among the most challenging are planning and executing the logistics of the trial’s clinical supplies. This podcast focuses in depth on the following topics which trace current practices and future evolution of this crucial aspect of clinical trials:

  • Current practices in clinical trial logistics
  • Comparing advances in clinical supply practices to  other aspects of clinical trials 
  • Where current practices fall short of meeting the challenges
  • Trends and evolving improvements that may change the way logistics are conducted

Listen Now  


More Podcasts

Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 





Sponsored Links

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .